Kaiima Bio-Agritech

Kaiima Bio-Agritech

Private
IsraelHealthcare & Life Scienceshttp://www.kaiima.com

Last Round

Series C

Sep 3, 2013

Est. Valuation

$40M

Total Funding Raised

$83M

Company Overview

Kaiima Bio-Agritech is a plant genetics and breeding technology company that develops platforms to improve crop productivity for sustainable agriculture. The company initially developed a non-GMO platform called EP™ (Enhanced Ploidy), which induces genomic diversity to boost yield and resource efficiency in crops like corn, soy, and wheat. More recently, Kaiima has focused on the development and commercialization of castor bean hybrids through its CastorMaxx® platform. This platform aims to establish castor as a modern, profitable crop for the production of castor oil, a renewable raw material for biofuels and biomaterials, aligning with the circular economy. Originally founded in Israel, the company now has its headquarters in Brazil and collaborates with partners like Embrapa to strengthen the castor production chain. The company has also formed joint ventures, such as BioKaiima in Mexico, to commercialize its castor hybrid seeds.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Alternative Fuels, Sustainable Materials

Business Model

B2B

Customer Profile

Services & Consulting, Revenue Share

AI Layer

Non-AI

Keywords

castor bean hybridshybrid seedsplant breedingagritechnon-GMO breedingseed techcrop yield enhancementplant geneticscrop sciencecastor oil productionmechanized harvestingbiofuelsbiomaterialsagronomic support

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Kaiima Bio-Agritech Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Kaiima Bio-Agritech Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
Series CSep 3, 2013
Series BApr 5, 2011

Kaiima Bio-Agritech Investors

Notable investors and investment history

Kaiima Bio-Agritech Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Kaiima Bio-Agritech Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Kaiima Bio-Agritech's valuation, stock price, and market status.

Firmographic Details

HeadquartersIsrael
Year Founded2007
Last FundingSep 3, 2013

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.